Orange Book product · Generic (ANDA)
ANGIOVIST 282
DIATRIZOATE MEGLUMINE
At a glance
Sep 23, 1982
Approved
Generic (ANDA)
Application
Not listed
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Sep 23, 1982
44 yr 5 mo ago
Today
Pharmaceutical detail
Active ingredient
DIATRIZOATE MEGLUMINE
Strength
60%
Dosage form
INJECTABLE
Route
INJECTION
TE code
Not listed
Application
ANDA 087726
Product number
001
Marketing status
DISCN
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of DIATRIZOATE MEGLUMINE
- —CARDIOGRAFINBrand (NDA)
NDA 011620 · BRACCO
- —DIATRIZOATE MEGLUMINEBrand (NDA)
NDA 010040 · BRACCO
- —HYPAQUEBrand (NDA)
NDA 016403 · GE HEALTHCARE
- 1982UROVIST MEGLUMINE DIU/CTGeneric (ANDA)
ANDA 087739 · BAYER HLTHCARE
- 1982UROVIST CYSTOGeneric (ANDA)
ANDA 087729 · BAYER HLTHCARE
- 1982UROVIST CYSTO PEDIATRICGeneric (ANDA)
ANDA 087731 · BAYER HLTHCARE
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
